Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Research and Markets: 2014-2018 US Critical Care Diagnostic Testing in Ancillary Hospital Locations (ER, OR, ICU): Volume and Sales Forecasts, Emerging Technologies, Competitive Strategies

BIOGY

Research and Markets (http://www.researchandmarkets.com/research/9zlx33/20142018_us) has announced the addition of the "2014-2018 US Critical Care Diagnostic Testing in Ancillary Hospital Locations (ER, OR, ICU): Volume and Sales Forecasts, Emerging Technologies, Competitive Strategies" report to their offering.

This 973-page report contains 153 tables and provides comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs). The report includes analysis of the market dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. We trust, this report will help diagnostic products suppliers develop more effective business, R&D and marketing strategies.

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals closer to the patient.

Market Segmentation Analysis

  • Review of the ER, OR and ICU market segments, including their dynamics, trends, structure, size, growth and major suppliers.
  • Five-year test volume and sales forecasts for chemistry, immunodiagnostic, microbiology, hematology and coagulation procedures by market segment:
  • Emergency Rooms
  • Operating/Recovery Suites
  • ICUs/CCUs and test category:
  • Routine and Special Chemistry
  • Microbiology/Infectious Diseases
  • Hematology
  • Flow Cytometry
  • Coagulation
  • Immunoproteins
  • Drugs of Abuse
  • TDM
  • Endocrine Function
  • Tumor Markers

Sales and Market Share Analysis

  • Sales and market shares of major reagent and instrument suppliers.

Current and Emerging Products

  • Analysis of over 130 diagnostic procedures.
  • Review of leading POC chemistry, immunoassay, hematology and coagulation analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices.

Technology Review

  • Emerging technologies and their applications for POC testing.
  • Comprehensive listings of companies developing or marketing POC diagnostic technologies and products, by test.

Competitive Assessments

  • Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.

Strategic Recommendations

  • Specific opportunities for new POC instruments and reagent systems with potentially significant market appeal during the next ten years.
  • Design criteria for POC testing products.
  • Alternative business expansion strategies.
  • Potential market entry barriers and risks.

For more information visit http://www.researchandmarkets.com/research/9zlx33/20142018_us

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: In Vitro Diagnostics